SOCCAR: Sequential or concurrent chemotherapy and hypofractionated accelerated radiotherapy in inoperable stage III NSCLC

被引:3
|
作者
Maguire, J.
McMenemin, R.
O'Rourke, N.
Peedell, C.
Snee, M.
Mcnee, S.
Kelly, V.
机构
[1] Clatterbridge Ctr Oncol, Bebington, England
[2] Freeman Rd Hosp, Northern Ctr Canc Care, Dept Clin Oncol, Newcastle Upon Tyne NE7 7DN, Tyne & Wear, England
[3] Western Infirm & Associated Hosp, Beatson Oncol Ctr, Glasgow G11 6NT, Lanark, Scotland
[4] James Cook Univ Hosp, Middlesbrough, Cleveland, England
[5] St James Inst Oncol, Leeds, W Yorkshire, England
[6] Liverpool Heart & Chest Hosp, Liverpool, Merseyside, England
关键词
D O I
10.1200/jco.2011.29.15_suppl.7039
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
7039
引用
下载
收藏
页数:1
相关论文
共 50 条
  • [21] Propensity-matched analysis of concurrent/sequential versus sequential immune checkpoint inhibition in inoperable stage III NSCLC patients treated with chemoradiotherapy.
    Kaesmann, Lukas
    Taugner, Julian
    Eze, Chukwuka
    Guggenberger, Julian
    Kenndoff, Saskia
    Floersch, Benedikt
    Tufman, Amanda
    Reinmuth, Niels
    Belka, Claus
    Manapov, Farkhad
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [22] Hypofractionated accelerated radiotherapy with concurrent chemotherapy for locally advanced squamous cell carcinoma of the head and neck
    Sanghera, Paul
    McConkey, Cris
    Ho, Kean-Fatt
    Glaholm, John
    Hartley, Andrew
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2007, 67 (05): : 1342 - 1351
  • [23] Toxicity of Hypofractionated Accelerated Radiotherapy Concurrent with Chemotherapy for Non-small Cell Carcinoma of the Lung
    Carruthers, R.
    O'Rourke, N.
    Mohammed, N.
    Hicks, J.
    Brisbane, I.
    CLINICAL ONCOLOGY, 2011, 23 (08) : 561 - 562
  • [24] ACCELERATED HYPOFRACTIONATED RADIOTHERAPY IN INOPERABLE LUNG CANCER USINGTOMOTHERAPY: THE LAUSANNE EXPERIENCE
    Bouchaab, H.
    Peters, S.
    Ris, H. B.
    Tsoutsou, P.
    Mirimanoff, R. O.
    Ozsahin, M.
    Matzinger, O.
    JOURNAL OF THORACIC ONCOLOGY, 2012, 7 (06) : S55 - S55
  • [25] Prolonged survival in inoperable NSCLC with concurrent chemo-radiotherapy
    Maguire, J
    Page, R
    Kelly, V
    Smith, N
    Ledson, M
    Walshaw, M
    THORAX, 2002, 57
  • [26] Concurrent accelerated hyperfractionation radiotherapy and chemotherapy for stage III non-small cell lung cancer.
    Hitoshi, Y
    Toshiaki, T
    Noriko, H
    Tetsuro, T
    Kazoro, I
    Etsuko, T
    Teruhiko, I
    Yoshiaki, S
    Hideaki, O
    Satoshi, F
    Fumiaki, U
    Hajime, O
    Hideo, U
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1997, 39 (02): : 315 - 315
  • [27] Pilot study of accelerated radiotherapy with concurrent chemotherapy for stage III non-small cell lung cancer
    Machtay, M
    Washam, C
    Devine, P
    SEMINARS IN ONCOLOGY, 2005, 32 (02) : S9 - S12
  • [28] Treatment patterns and prognosis in inoperable stage III NSCLC treated with concurrent CRT plus /- ICI
    Floersch, B.
    Taugner, J.
    Kaemann, L.
    Kenndoff, S.
    Guggenberger, J.
    Tufman, A.
    Reinmuth, N.
    Duell, T.
    Belka, C.
    Eze, C.
    Manapov, F.
    RADIOTHERAPY AND ONCOLOGY, 2022, 170 : S1056 - S1057
  • [29] Hypofractionated stereotactic radiotherapy (hSRT) of NSCLC stage I
    Zimmermann, F
    STRAHLENTHERAPIE UND ONKOLOGIE, 2005, 181 : 86 - 86
  • [30] Stereotactic ablative radiotherapy for inoperable stage I NSCLC
    Andratschke, Nicolaus
    LANCET ONCOLOGY, 2012, 13 (08): : 746 - 748